SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies (ROLR) is generating significant buzz after announcing a strategic partnership with crypto.com/us to enter the burgeoning prediction markets in the USA, alongside its plans for sports betting expansion. The active community discussion centers on the stock's exceptionally low float and recent profitability, fueling speculation of a massive short squeeze and drawing comparisons to other high-momentum market plays.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending amid strong investor anticipation for major news, with the community highly focused on its patented Optical Interposer technology as a critical enabler for AI and hyperscale data centers. Discussion highlights the potential for large production orders and strategic partnerships, intensified by recent institutional investments and the Marvell/Celestial AI acquisition as key validators. Despite perceived market manipulation around options expiry, many believe POET is on the cusp of significant growth, poised to revolutionize data transfer efficiency in AI infrastructure.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is highly active as market participants anticipate the outcome of crucial high-level discussions between US and Greenland/Denmark officials regarding Greenland's strategic minerals and geopolitical role. The community is buzzing with speculation around a potential agreement, driving strong discussion of a short squeeze and highlighting the company's recent positive drilling results from its Tanbreez project. This intense focus reflects broader interest in securing critical rare earth element supply chains.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

The Metals Company ($TMC) is trending following the White House's approval of NOAA's revised deep seabed mining regulations, a critical development that removes a major procedural bottleneck and accelerates the path to commercial recovery permits. The community is highly bullish, emphasizing this de-risking event and the strategic importance of deep-sea minerals for U.S. independence. This regulatory clarity, combined with recent bullish insider activity, is fueling strong conviction and anticipation of a significant upward repricing among investors.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is a central topic of conversation, driven by positive Phase 2 data for its obesity drug VK2735 and recent remarks from a peer CEO about substantial M&A in the weight-loss market. The community is intensely focused on the potential for a major partnership or acquisition, debating VK2735's "best-in-class" attributes and its oral formulation's path to Phase 3 amid strong competition.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is experiencing notable selling pressure, sparking community debate over its underperformance compared to tech peers and immediate downside potential influenced by options dynamics. Amidst this, conversations are actively centered on the financial implications of its substantial AI infrastructure investments, including data center energy costs, and the competitive landscape surrounding its OpenAI partnership, leading many to consider current levels a strategic buying opportunity.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is garnering significant attention as a crucial player in the booming AI data center market, with its advanced GaN and SiC power solutions directly supporting high-efficiency architectures, including Nvidia's. The community is actively discussing the company's upcoming presentation at a major industry conference, speculating on potential contract announcements and the impact of substantial short interest. This creates a strong buzz around the stock's growth prospects and potential for a significant market move.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is experiencing a parabolic ascent, driven by surging physical silver premiums in Asian markets, the US Mint halting sales, and persistent geopolitical tensions. The community is actively discussing a massive short squeeze on institutional players, who are reportedly being forced to cover positions amidst tightening supply and surging industrial demand for silver in sectors like AI and EVs.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is actively trending following widespread reports of a significant network outage across various regions, sparking frustration among users and prompting discussions about service reliability and potential causes like cyberattacks. This comes as the company recently affirmed its financial outlook and commitment to its substantial dividend, leading to a split in community sentiment between immediate service concerns and the stock's long-term value as an income play. Many are questioning the impact on future subscriber loyalty while weighing recent operational restructuring and strategic investments in 5G and fiber.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

The biotech sector is abuzz with TG Therapeutics following robust preliminary revenue figures and optimistic guidance for its lead drug, Briumvi, reinforcing its blockbuster potential. Despite the strong performance, community discussion highlights significant frustration over ongoing price volatility and perceived market manipulation, with many questioning why the stock struggles to sustain gains. Amid calls for a potential buyout or aggressive share repurchases, investors are eagerly awaiting further details and clarity on future growth drivers like the subcutaneous formulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

WATCHLIST SEP 26 2025

$KURA Kura Oncology Announces The Journal Of Clinical Oncology Published The Full Results From The Pivotal KOMET-001 Clinical Trial Evaluating Ziftomenib; KOMET-001 In R/r Npm1-m AML Met Its Primary Endpoint With Ziftomenib Monotherapy Demonstrating Significant Clinical Benefit And Deep Responses

$WSFS TD Cowen Initiates Coverage On WSFS Financial with Buy Rating, Announces Price Target of $67

$CRNX Crinetics Pharmaceuticals Receives FDA Approval For PALSONIFY; PALSONIFY Is Expected To Be Available In The U.S. In Early October

$BA Boeing Announces Turkish Airlines Order For 75 Boeing 787 Dreamliners And Norwegian Group Agreement For 30 Boeing 737 MAX Aircraft

$EWM United States Considering Tariff Exemptions For Malaysia Commodities And Zero Tariffs On Furniture Automotive And Aerospace

Rick Glowaki

HHHHH

DueDick

Peter Quick

ChessGM

Oscar Angel

Shanna W

StockTwits for iOS

Kura Oncology Inc

WSFS Financial Corp.

Crinetics Pharmaceuticals Inc

Boeing Co

iShares MSCI Malaysia ETF

 Kura Oncology Announces The Journal Of Clinical Oncology Published The Full Results From The Pivotal KOMET-001 Clinical Trial Evaluating Ziftomenib; KOMET-001 In R/r Npm1-m AML Met Its Primary Endpoint With Ziftomenib Monotherapy Demonstrating Significant Clinical Benefit And Deep Responses



 TD Cowen Initiates Coverage On WSFS Financial with Buy Rating, Announces Price Target of $67



 Crinetics Pharmaceuticals Receives FDA Approval For PALSONIFY; PALSONIFY Is Expected To Be Available In The U.S. In Early October



 Boeing Announces Turkish Airlines Order For 75 Boeing 787 Dreamliners And Norwegian Group Agreement For 30 Boeing 737 MAX Aircraft



 United States Considering Tariff Exemptions For Malaysia Commodities And Zero Tariffs On Furniture Automotive And Aerospace